Apella Capital LLC Invests $9.72 Million in iShares Biotechnology ETF $IBB

Apella Capital LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 57,594 shares of the financial services provider’s stock, valued at approximately $9,720,000. Apella Capital LLC owned 0.12% of iShares Biotechnology ETF at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $25,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Parkside Financial Bank & Trust boosted its stake in iShares Biotechnology ETF by 48.6% in the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 87 shares during the period. Close Asset Management Ltd boosted its stake in iShares Biotechnology ETF by 25.5% in the 3rd quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after purchasing an additional 70 shares during the period. Finally, Founders Financial Alliance LLC boosted its stake in iShares Biotechnology ETF by 605.7% in the 3rd quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 321 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $168.83 on Tuesday. The business has a fifty day simple moving average of $170.44 and a 200 day simple moving average of $165.48. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.